Acute kidney injury in patients with COVID-19 in the intensive care unit: evaluation of risk factors and mortality in a national cohort

Objectives Acute kidney injury (AKI) is a frequent complication among critical ill patients with COVID-19, but the actual incidence is unknown as AKI-incidence varies from 25% to 89% in intensive care unit (ICU) populations. We aimed to describe the prevalence and risk factors of AKI in patients wit...

Full description

Saved in:
Bibliographic Details
Main Authors: Pål Klepstad, Eirik Aasen Aukland, Stein Magnus Aukland, Fatemeh Zamanzad Ghavidel, Eirik Alnes Buanes
Format: Article
Language:English
Published: BMJ Publishing Group 2022-06-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/6/e059046.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832574949419646976
author Pål Klepstad
Eirik Aasen Aukland
Stein Magnus Aukland
Fatemeh Zamanzad Ghavidel
Eirik Alnes Buanes
author_facet Pål Klepstad
Eirik Aasen Aukland
Stein Magnus Aukland
Fatemeh Zamanzad Ghavidel
Eirik Alnes Buanes
author_sort Pål Klepstad
collection DOAJ
description Objectives Acute kidney injury (AKI) is a frequent complication among critical ill patients with COVID-19, but the actual incidence is unknown as AKI-incidence varies from 25% to 89% in intensive care unit (ICU) populations. We aimed to describe the prevalence and risk factors of AKI in patients with COVID-19 admitted to ICU in Norway.Design Nation-wide observational study with data sampled from the Norwegian Intensive Care and Pandemic Registry (NIPaR) for the period between 10 March until 31 December 2020.Setting ICU patients with COVID-19 in Norway. NIPaR collects data on intensive care stays covering more than 90% of Norwegian ICU and 98% of ICU stays.Participants Adult patients with COVID-19 admitted to Norwegian ICU were included in the study. Patients with chronic kidney disease (CKD) were excluded in order to avoid bias from CKD on the incidence of AKI.Primary and secondary outcome measures Primary outcome was AKI at ICU admission as defined by renal Simplified Acute Physiology Score in NIPaR. Secondary outcome measures included survival at 30 and 90 days after admission to hospital.Results A total number of 361 patients with COVID-19 were included in the analysis. AKI was present in 32.0% of the patients at ICU admission. The risk for AKI at ICU admission was related to acute circulatory failure at admission to hospital. Survival for the study population at 30 and 90 days was 82.5% and 77.6%, respectively. Cancer was a predictor of 30-day mortality. Age, acute circulatory failure at hospital admission and AKI at ICU admission were predictors of both 30-day and 90-day mortality.Conclusions A high number of patients with COVID-19 had AKI at ICU admission. The study indicates that AKI at ICU admission was related to acute circulatory failure at hospital admission. Age, acute circulatory failure at hospital admission and AKI at ICU admission were associated with mortality.
format Article
id doaj-art-fb8a1c472b794190b7c03ea18014334a
institution Kabale University
issn 2044-6055
language English
publishDate 2022-06-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-fb8a1c472b794190b7c03ea18014334a2025-02-01T13:00:12ZengBMJ Publishing GroupBMJ Open2044-60552022-06-0112610.1136/bmjopen-2021-059046Acute kidney injury in patients with COVID-19 in the intensive care unit: evaluation of risk factors and mortality in a national cohortPål Klepstad0Eirik Aasen Aukland1Stein Magnus Aukland2Fatemeh Zamanzad Ghavidel3Eirik Alnes Buanes4Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, NorwayFaculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, NorwayDepartment of Radiology, Haukeland University Hospital, Bergen, NorwayDepartment of Research and Development, Haukeland University Hospital, Bergen, NorwayNorwegian Intensive Care and Pandemic Registry, Bergen, NorwayObjectives Acute kidney injury (AKI) is a frequent complication among critical ill patients with COVID-19, but the actual incidence is unknown as AKI-incidence varies from 25% to 89% in intensive care unit (ICU) populations. We aimed to describe the prevalence and risk factors of AKI in patients with COVID-19 admitted to ICU in Norway.Design Nation-wide observational study with data sampled from the Norwegian Intensive Care and Pandemic Registry (NIPaR) for the period between 10 March until 31 December 2020.Setting ICU patients with COVID-19 in Norway. NIPaR collects data on intensive care stays covering more than 90% of Norwegian ICU and 98% of ICU stays.Participants Adult patients with COVID-19 admitted to Norwegian ICU were included in the study. Patients with chronic kidney disease (CKD) were excluded in order to avoid bias from CKD on the incidence of AKI.Primary and secondary outcome measures Primary outcome was AKI at ICU admission as defined by renal Simplified Acute Physiology Score in NIPaR. Secondary outcome measures included survival at 30 and 90 days after admission to hospital.Results A total number of 361 patients with COVID-19 were included in the analysis. AKI was present in 32.0% of the patients at ICU admission. The risk for AKI at ICU admission was related to acute circulatory failure at admission to hospital. Survival for the study population at 30 and 90 days was 82.5% and 77.6%, respectively. Cancer was a predictor of 30-day mortality. Age, acute circulatory failure at hospital admission and AKI at ICU admission were predictors of both 30-day and 90-day mortality.Conclusions A high number of patients with COVID-19 had AKI at ICU admission. The study indicates that AKI at ICU admission was related to acute circulatory failure at hospital admission. Age, acute circulatory failure at hospital admission and AKI at ICU admission were associated with mortality.https://bmjopen.bmj.com/content/12/6/e059046.full
spellingShingle Pål Klepstad
Eirik Aasen Aukland
Stein Magnus Aukland
Fatemeh Zamanzad Ghavidel
Eirik Alnes Buanes
Acute kidney injury in patients with COVID-19 in the intensive care unit: evaluation of risk factors and mortality in a national cohort
BMJ Open
title Acute kidney injury in patients with COVID-19 in the intensive care unit: evaluation of risk factors and mortality in a national cohort
title_full Acute kidney injury in patients with COVID-19 in the intensive care unit: evaluation of risk factors and mortality in a national cohort
title_fullStr Acute kidney injury in patients with COVID-19 in the intensive care unit: evaluation of risk factors and mortality in a national cohort
title_full_unstemmed Acute kidney injury in patients with COVID-19 in the intensive care unit: evaluation of risk factors and mortality in a national cohort
title_short Acute kidney injury in patients with COVID-19 in the intensive care unit: evaluation of risk factors and mortality in a national cohort
title_sort acute kidney injury in patients with covid 19 in the intensive care unit evaluation of risk factors and mortality in a national cohort
url https://bmjopen.bmj.com/content/12/6/e059046.full
work_keys_str_mv AT palklepstad acutekidneyinjuryinpatientswithcovid19intheintensivecareunitevaluationofriskfactorsandmortalityinanationalcohort
AT eirikaasenaukland acutekidneyinjuryinpatientswithcovid19intheintensivecareunitevaluationofriskfactorsandmortalityinanationalcohort
AT steinmagnusaukland acutekidneyinjuryinpatientswithcovid19intheintensivecareunitevaluationofriskfactorsandmortalityinanationalcohort
AT fatemehzamanzadghavidel acutekidneyinjuryinpatientswithcovid19intheintensivecareunitevaluationofriskfactorsandmortalityinanationalcohort
AT eirikalnesbuanes acutekidneyinjuryinpatientswithcovid19intheintensivecareunitevaluationofriskfactorsandmortalityinanationalcohort